OAC
KRYS icon

OMERS Administration Corp’s Krystal Biotech KRYS Stock Holding History

OMERS Administration Corp’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.44M Sell
3,880
-220
-5% -$65.7K 0.01% 620
2026
Q1 		$1.06M Buy
+4,100
New +$1.09M 0.01% 639
2025
Q4 		– Sell
-4,000
Closed -$706K – 1210
2025
Q3 		$706K Buy
+4,000
New +$599K 0.01% 651
2024
Q2 		– Sell
-8,200
Closed -$1.46M – 1140
2024
Q1 		$1.46M Buy
+8,200
New +$1.14M 0.02% 138

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

OMERS Administration Corp's KRYS Position: Q2 2026 in Review

OMERS Administration Corp reduced its Krystal Biotech (KRYS) stake by 5.4% in Q2 2026, selling an estimated $65.7K and leaving 3,880 shares worth $1.44M. The position accounts for 0.01% of the portfolio, ranked #620.

OMERS Administration Corp first reported a position in KRYS in Q1 2024 and has held it in 4 quarters since. The position peaked at $1.46M in Q1 2024. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • OMERS Administration Corp held 3,880 shares of Krystal Biotech worth $1.44M as of Q2 2026.
  • OMERS Administration Corp sold 220 Krystal Biotech shares in Q2 2026, an estimated $65.7K.
  • Krystal Biotech made up 0.01% of OMERS Administration Corp's portfolio in Q2 2026, its #620 holding.
  • OMERS Administration Corp first reported a position in Krystal Biotech in Q1 2024 and has held it in 4 quarters since.
  • OMERS Administration Corp's Krystal Biotech position peaked at $1.46M in Q1 2024.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.